Actimed Therapeutics Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
Study of Comparative Bioavailability and Pharmacokinetics of ACM-001.1) and Pindolol in Healthy Volunteers (HV)
Phase 1
Completed
- Conditions
- Cachexia
- Interventions
- Drug: Part 1 Group 2 Regimen C (Pindolol)Drug: Part 1 Group 1 Regime A (ACM-001.1)Drug: Part 2 Group G (ACM-001.1)Drug: Part 2 Group D (Pindolol)Drug: Part 2 Group E (ACM-001.1)Drug: Part 2 Group F (ACM-001.1 )Drug: Part 1 Group 1 Regimen B (Pindolol)Other: Part 2 Group G ( Placebo)Other: Part 2 Group E (Placebo)Other: Part 2 Group F (Placebo)Other: Part 1 Group 1 Regimen A (Placebo)
- First Posted Date
- 2023-09-08
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Actimed Therapeutics Ltd
- Target Recruit Count
- 51
- Registration Number
- NCT06028321
- Locations
- 🇬🇧
Quotient Sciences Ltd, Ruddington, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath